Literature DB >> 26297123

Further evidence supporting the association of NKAPL with schizophrenia.

Zhiqiang Wang1, Bixiu Yang1, Yansong Liu2, Yin Yao Shugart3, Zaohuo Cheng2, Chunhui Jin2, Jianmin Yuan2, Wei Zhu2, Guoqiang Wang4, Fuquan Zhang5.   

Abstract

Schizophrenia (SZ) is a severe chronic mental disorder with complex genetic mechanisms. Increasing evidence implicate immune system dysfunction in the pathogenesis of SZ. The non-synonymous single nucleotide polymorphism (SNP) rs1635 in NKAPL, was identified by a genome-wide association study (GWAS) for SZ in Han Chinese from north China. A replication study failed to detect the association of rs1635 with SZ in Han Chinese from central south of China, while another one confirmed the positive association in Han Chinese from Taiwan. To further clarify these findings, we conducted a case-control association study of rs1635 in a cohort of Han Chinese from east China, including 1406 SZ cases and 1136 healthy controls. We detected a positive association of rs1635 with SZ, with the major allele (G) of rs1635 conferring a risk for SZ (P=0.033, OR=1.14). Our findings add further evidence for the involvement of NKAPL polymorphisms in the development of SZ.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  NKAPL; Schizophrenia; rs1635

Mesh:

Substances:

Year:  2015        PMID: 26297123     DOI: 10.1016/j.neulet.2015.08.023

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Association between NF-κB Pathway Gene Variants and sICAM1 Levels in Taiwanese.

Authors:  Semon Wu; Ming-Sheng Teng; Leay-Kiaw Er; Wan-Yi Hsiao; Lung-An Hsu; Ching-Hua Yeh; Jeng-Feng Lin; Yi-Ying Lin; Cheng-Wen Su; Yu-Lin Ko
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

2.  BDNF Gene's Role in Schizophrenia: From Risk Allele to Methylation Implications.

Authors:  Xiaoqian Fu; Jun Wang; Jianbin Du; Jing Sun; Ancha Baranova; Fuquan Zhang
Journal:  Front Psychiatry       Date:  2020-12-15       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.